๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients

โœ Scribed by Y. Akanuma; M. Morita; N. Fukuzawa; T. Yamanouchi; H. Akanuma


Publisher
Springer
Year
1988
Tongue
English
Weight
462 KB
Volume
31
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

โœฆ Synopsis


The urinary excretion of 1,5-anhydro-D-glucitol, a pyranoid polyol, in humans was studied. The plasma of nondiabetic human subjects contained high concentrations of this polyol (greater than 110 mumol/l), and there was a tendency for the 24-h excretion of it to become more variable in direct proportion to its plasma concentration. In contrast, diabetic patients showed lower plasma concentrations of this polyol, and the variation in the 24-h excretion of 1,5-anhydro-D-glucitol was especially notable among the patients with an extremely low plasma concentration of the polyol. This diabetic group showed a statistically significant correlation (p less than 0.01), between the urinary 1,5-anhydro-D-glucitol and urinary glucose. This correlation was more markedly demonstrated during a 100-g oral glucose tolerance test: parallel changes were observed in the concentrations of 1,5-anhydro-D-glucitol and glucose in the urine collected every hour after the glucose load. These observations led to the proposal that low plasma concentration of this polyol, which is observed in diabetes mellitus, may be the result of a frequent and/or prolonged high blood glucose concentration beyond the renal threshold for glucose excretion.


๐Ÿ“œ SIMILAR VOLUMES


Urinary excretion of phenobarbitone and
โœ I. Bernus; R. G. Dickinson; W. D. Hooper; M. J. Eadie ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› Springer ๐ŸŒ English โš– 305 KB

The elimination of phenobarbitone (PB) was studied in 14 chronically treated epileptic patients under steady state conditions. PB, [S]-PB-N-glucoside ( [S]-PB-N-G) and p-hydroxy-PB (p-OH-PB) were assayed in urine by a HPLC method. Some 57 % of the daily dose was recovered in urine, 14 % as [S]-PB-N

Abnormalities in plasmas concentrations
โœ T. Jensen; S. Stender; T. Deckert ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 475 KB

Type 1 (insulin-dependent) diabetic patients with clinical nephropathy have a more than ten-fold increase in mortality of cardiovascular diseases compared with diabetic patients without nephropathy. The risk factors for cardiovascular disease, plasma concentrations of lipoproteins and fibrinogen, we